These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto. Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590 [TBL] [Abstract][Full Text] [Related]
3. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033 [TBL] [Abstract][Full Text] [Related]
4. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding. Tripodi A; Krachmalnicoff A; Mannucci PM Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966 [TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding. Jørgensen M; Petersen LC; Thorsen S J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440 [TBL] [Abstract][Full Text] [Related]
6. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin. Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187 [TBL] [Abstract][Full Text] [Related]
7. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis. Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509 [TBL] [Abstract][Full Text] [Related]
8. A new familial variant of antithrombin III: 'antithrombin III Paris'. Wolf M; Boyer C; Lavergne JM; Larrieu MJ Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587 [TBL] [Abstract][Full Text] [Related]
9. Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiency. Wolf M; Boyer-Neumann C; Molho-Sabatier P; Neumann C; Meyer D; Larrieu MJ Thromb Haemost; 1990 Apr; 63(2):215-9. PubMed ID: 2363123 [TBL] [Abstract][Full Text] [Related]
10. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity. Owen MC; Beresford CH; Carrell RW FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140 [TBL] [Abstract][Full Text] [Related]
11. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis. Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391 [TBL] [Abstract][Full Text] [Related]
12. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity. de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409 [TBL] [Abstract][Full Text] [Related]
13. Antithrombin III Alger: a new homozygous AT III variant. Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788 [TBL] [Abstract][Full Text] [Related]
14. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity. Howarth DJ; Samson D; Stirling Y; Seghatchian MJ Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307 [TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation. de Roux N; Chadeuf G; Molho-Sabatier P; Plouin PF; Aiach M Br J Haematol; 1990 Jun; 75(2):222-7. PubMed ID: 2372510 [TBL] [Abstract][Full Text] [Related]
16. Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma). De Stefano V; Leone G; Ferrelli R; Di Donfrancesco A; De Martini D; Bizzi B Thromb Res; 1987 Oct; 48(1):23-30. PubMed ID: 3424283 [TBL] [Abstract][Full Text] [Related]
17. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy. Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508 [TBL] [Abstract][Full Text] [Related]
18. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver"). Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602 [TBL] [Abstract][Full Text] [Related]
19. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk. Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067 [No Abstract] [Full Text] [Related]
20. Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern. Leone G; De Stefano V; Di Donfrancesco A; Ferrelli R; Traisci G; Bizzi B Br J Haematol; 1987 Feb; 65(2):187-91. PubMed ID: 3828226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]